Abstract
Methylation of CpG islands is associated with transcriptional silencing and the formation of nuclease-resistant chromatin structures enriched in hypoacetylated histones1,2,3. Methyl-CpG-binding proteins, such as MeCP2, provide a link between methylated DNA and hypoacetylated histones by recruiting histone deacetylase4,5, but the mechanisms establishing the methylation patterns themselves are unknown. Whether DNA methylation is always causal for the assembly of repressive chromatin or whether features of transcriptionally silent chromatin might target methyltransferase remains unresolved. Mammalian DNA methyltransferases show little sequence specificity in vitro, yet methylation can be targeted in vivo within chromosomes to repetitive elements6,7, centromeres8,9,10 and imprinted loci11. This targeting is frequently disrupted in tumour cells, resulting in the improper silencing of tumour-suppressor genes associated with CpG islands1,2. Here we show that the predominant mammalian DNA methyltransferase, DNMT1, co-purifies with the retinoblastoma (Rb) tumour suppressor gene product, E2F1, and HDAC1 and that DNMT1 cooperates with Rb to repress transcription from promoters containing E2F-binding sites. These results establish a link between DNA methylation, histone deacetylase and sequence-specific DNA binding activity, as well as a growth-regulatory pathway that is disrupted in nearly all cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Issa, J.-P., Baylin, S.B. & Herman, J.G. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia 11, 7–11 (1997).
Jones, P.A. & Laird, P.W. Cancer epigenetics comes of age. Nature Genet. 21, 163–166 (1999).
Eden, S., Hashimshony, T., Keshet, I., Cedar, H. & Thorne, A.W. DNA methylation models histone acetylation. Nature 394, 842 (1998).
Jones, P.L. et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nature Genet. 19, 187–191 (1998).
Nan, X. et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 invloves a histone deacetylase complex. Nature 393, 386–389 (1998).
Luff, B., Pawlowski, L. & Bender, J. An inverted repeat triggers cytosine methylation of identical sequences in Arabidopsis. Mol. Cell 3, 505–511 (1999).
Garrick, D., Fiering, S., Martin, D.I. & Whitelaw, E. Repeat-induced gene silencing in mammals. Nature Genet. 18, 56–59 (1998).
Hansen, R.S. et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc. Natl Acad. Sci. USA 96, 14412–14417 (1999).
Okano, M., Bell, D.W., Haber, D.A. & Li, W. DNA methyltransferases DNMT3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257 (1999).
Xu, G.-L. et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402, 187–191 (1999).
Surani, M.A. Imprinting and the initiation of gene silencing in the germ line. Cell 93, 309–312 (1998).
Li, E., Bestor, T.H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926 (1992).
Leonhardt, H., Page, A.W., Weier, H. & Bestor, T.H. A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71, 865–873 (1992).
Fuks, F., Bergers, W.A., Brehm, A., Hughes-Davies, L. & Kouzarides, T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nature Genet. 24, 88–91 (2000).
Dunaief, J.L. et al. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79, 119–130 (1994).
Chuang, L.S.-H. et al. Human DNA-(cytosine-5) methyltransferase-PCNA complex is a target for p21Waf1. Science 277, 1996–2000 (1997).
Grana, X., Garriga, J. & Mayol, X. Role of the retinoblastoma protein family, pRB, p107, and p130 in the negative control of cell growth. Oncogene 17, 3365–3383 (1998).
Robertson, K.D. & Jones, P.A. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol 18, 6457–6473 (1998).
Luo, R.X., Postigo, A.A. & Dean, D.C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473 (1998).
Magnaghi-Jaulin, L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 535–536 (1998).
Royzman, I., Austin, R.J., Bosco, G., Bell, S.P. & Orr-Weaver, T.L. ORC localization in Drosophila follicle cells and the effects of mutations in dE2F and dDP. Genes Dev. 13, 827–840 (1999).
Sterner, J.M., Dew-Knight, S., Musahl, C., Kornbluth, S. & Horowitz, J.M. Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7. Mol. Cell. Biol. 18, 2748–2757 (1998).
Hung, M.-S. et al. Drosophila proteins related to vertebrate DNA (5-cytosine) methyltransferases. Proc. Natl Acad. Sci. USA 96, 11940–11945 (1999).
Issa, J.-P. et al. Increased DNA-methyltransferase activity during colon cancer progression. J. Natl Cancer Inst. 85, 1235–1240 (1993).
Smith, S.S., Kaplan, B.E., Sowers, L.C. & Newman, E.M. Mechanism of human methyl-directed DNA methyltransferase and the fidelity of cytosine methylation. Proc. Natl Acad. Sci. USA 89, 4744–4748 (1992).
Robertson, K.D. et al. The human DNA methyltransferases (DNMTs) 1, 3a, and 3b: Coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res. 27, 2291–2298 (1999).
Ait-si-ali, S. et al. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396, 184–186 (1998).
Meehan, R.R., Lewis, J.D., McKay, S., Kleiner, E.L. & Bird, A.P. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58, 499–507 (1989).
Acknowledgements
We thank A. Harel-Bellan for providing the E2F1 and Rb vectors, and J.-M. Zingg for advice with the DNMT trapping assay. S.A was supported by an EMBO fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Robertson, K., Ait-Si-Ali, S., Yokochi, T. et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25, 338–342 (2000). https://doi.org/10.1038/77124
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/77124
This article is cited by
-
DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors
Scientific Reports (2023)
-
Environment factors, DNA methylation, and cancer
Environmental Geochemistry and Health (2023)
-
FK228 potentiates topotecan activity against small cell lung cancer cells via induction of SLFN11
Acta Pharmacologica Sinica (2022)
-
Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors
Journal of Cancer Research and Clinical Oncology (2021)
-
RFX1 downregulation contributes to TLR4 overexpression in CD14+ monocytes via epigenetic mechanisms in coronary artery disease
Clinical Epigenetics (2019)